| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACE inhibition and the kidney: species variation in the mechanisms responsible for the renal haemodynamic response
|
Lansang, M Cecilia
|
|
2000
|
1 |
2 |
p. 119-124
|
artikel
|
| 2 |
ACE inhibition and the kidney: species variation in the mechanisms responsible for the renal haemodynamic response
|
Lansang, M Cecilia
|
|
2000
|
1 |
2 |
p. 119-124
|
artikel
|
| 3 |
ACE inhibitors in hypertension: Still a shortage of evidence
|
Sever, Peter
|
|
2000
|
1 |
2 |
p. 117-118
|
artikel
|
| 4 |
ACE inhibitors in hypertension: Still a shortage of evidence
|
Sever, Peter
|
|
2000
|
1 |
2 |
p. 117-118
|
artikel
|
| 5 |
Angiotensin II does not mediate the pressor response to PGD2 (icv)
|
Kershenovich, Amir
|
|
2000
|
1 |
2 |
p. 195-200
|
artikel
|
| 6 |
Angiotensin II does not mediate the pressor response to PGD2 (icv)
|
Kershenovich, Amir
|
|
2000
|
1 |
2 |
p. 195-200
|
artikel
|
| 7 |
Angiotensin receptor blocker selectivity at the AT1- and AT2-receptors: conceptual and clinical effects
|
Unger, Thomas
|
|
2000
|
1 |
2 |
p. S6-S9
|
artikel
|
| 8 |
AT 1-signalling in vascular smooth muscle
|
Hughes, Alun D
|
|
2000
|
1 |
2 |
p. 125-130
|
artikel
|
| 9 |
AT 1-signalling in vascular smooth muscle
|
Hughes, Alun D
|
|
2000
|
1 |
2 |
p. 125-130
|
artikel
|
| 10 |
Binding characteristics of [3H]-irbesartan to human recombinant angiotensin type 1 receptors
|
Vanderheyden, Patrick ML
|
|
2000
|
1 |
2 |
p. 159-165
|
artikel
|
| 11 |
Binding characteristics of [3H]-irbesartan to human recombinant angiotensin type 1 receptors
|
Vanderheyden, Patrick ML
|
|
2000
|
1 |
2 |
p. 159-165
|
artikel
|
| 12 |
Cardiac, renal and vascular complications in the diabetic patient
|
Zanchetti, Alberto
|
|
2000
|
1 |
2 |
p. S21-S24
|
artikel
|
| 13 |
Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-ε in acutely reperfused myocardial infarction in the dog
|
Yi Xu,
|
|
2000
|
1 |
2 |
p. 184-195
|
artikel
|
| 14 |
Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-ε in acutely reperfused myocardial infarction in the dog
|
Yi Xu,
|
|
2000
|
1 |
2 |
p. 184-195
|
artikel
|
| 15 |
Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction
|
Gasparo, Marc de
|
|
2000
|
1 |
2 |
p. 151-158
|
artikel
|
| 16 |
Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction
|
Gasparo, Marc de
|
|
2000
|
1 |
2 |
p. 151-158
|
artikel
|
| 17 |
Erratum
|
|
|
2000
|
1 |
2 |
p. 124
|
artikel
|
| 18 |
Erratum
|
|
|
2000
|
1 |
2 |
p. 124-124
|
artikel
|
| 19 |
Hypertension and its management: a problem in need of new treatment strategies
|
Neutel, Joel M
|
|
2000
|
1 |
2 |
p. S10-S13
|
artikel
|
| 20 |
Improving the prognosis of diabetic patients: evaluating the role of intensive versus moderate blood pressure control with selective angiotensin II receptor blocker (ARB) therapy
|
Bedigian, Martin P
|
|
2000
|
1 |
2 |
p. S25-S28
|
artikel
|
| 21 |
Insights derived from ACE knockout mice
|
Cole, Justin
|
|
2000
|
1 |
2 |
p. 137-141
|
artikel
|
| 22 |
Insights derived from ACE knockout mice
|
Cole, Justin
|
|
2000
|
1 |
2 |
p. 137-141
|
artikel
|
| 23 |
Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan
|
Núñez, Antonio
|
|
2000
|
1 |
2 |
p. 175-179
|
artikel
|
| 24 |
Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan
|
Núñez, Antonio
|
|
2000
|
1 |
2 |
p. 175-179
|
artikel
|
| 25 |
Losartan reduces sympathetic nerve outflow from the brain of rats with chronic renal failure
|
Campese, Vito M
|
|
2000
|
1 |
2 |
p. 202-208
|
artikel
|
| 26 |
Losartan reduces sympathetic nerve outflow from the brain of rats with chronic renal failure
|
Campese, Vito M
|
|
2000
|
1 |
2 |
p. 202-208
|
artikel
|
| 27 |
Molecular mechanism(s) of insulin action on the expression of the angiotensinogen gene in kidney proximal tubular cells
|
Wu, Xiao-Hua
|
|
2000
|
1 |
2 |
p. 166-174
|
artikel
|
| 28 |
Molecular mechanism(s) of insulin action on the expression of the angiotensinogen gene in kidney proximal tubular cells
|
Wu, Xiao-Hua
|
|
2000
|
1 |
2 |
p. 166-174
|
artikel
|
| 29 |
New basic science initiatives with the angiotensin II receptor blocker valsartan
|
de Gasparo, Marc
|
|
2000
|
1 |
2 |
p. S3-S5
|
artikel
|
| 30 |
New clinical investigations with selective angiotensin II receptor blocker therapy in diabetes and renal disease
|
Ruilope, Luis M
|
|
2000
|
1 |
2 |
p. S29-S31
|
artikel
|
| 31 |
Nitric oxide mediates inhibitory effect of losartan on angiotensin-induced contractions in hamster but not rat aorta
|
Inoue, Kiyo
|
|
2000
|
1 |
2 |
p. 180-183
|
artikel
|
| 32 |
Nitric oxide mediates inhibitory effect of losartan on angiotensin-induced contractions in hamster but not rat aorta
|
Inoue, Kiyo
|
|
2000
|
1 |
2 |
p. 180-183
|
artikel
|
| 33 |
Ongoing clinical trials with angiotensin II receptor antagonists in chronic heart failure and myocardial infarction
|
McMurray, John
|
|
2000
|
1 |
2 |
p. 131-136
|
artikel
|
| 34 |
Ongoing clinical trials with angiotensin II receptor antagonists in chronic heart failure and myocardial infarction
|
McMurray, John
|
|
2000
|
1 |
2 |
p. 131-136
|
artikel
|
| 35 |
Pathological involvement of chymase-dependent angiotensin II formation in the development of cardiovascular disease
|
Urata, Hidenori
|
|
2000
|
1 |
2 |
p. S35-S37
|
artikel
|
| 36 |
Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure
|
Hanon, Sam
|
|
2000
|
1 |
2 |
p. 147-150
|
artikel
|
| 37 |
Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure
|
Hanon, Sam
|
|
2000
|
1 |
2 |
p. 147-150
|
artikel
|
| 38 |
Rationale for angiotensin II receptor blocker therapy in chronic heart failure
|
Cohn, Jay N
|
|
2000
|
1 |
2 |
p. S38-S40
|
artikel
|
| 39 |
Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy
|
McInnes, Gordon T
|
|
2000
|
1 |
2 |
p. S17-S20
|
artikel
|
| 40 |
The HF epidemic: the need for new treatment strategies
|
Carson, Peter E
|
|
2000
|
1 |
2 |
p. S32-S34
|
artikel
|
| 41 |
The renin angiotensin system and cardiovascular disease: hope or hype?
|
Williams, Bryan
|
|
2000
|
1 |
2 |
p. 142-146
|
artikel
|
| 42 |
The renin angiotensin system and cardiovascular disease: hope or hype?
|
Williams, Bryan
|
|
2000
|
1 |
2 |
p. 142-146
|
artikel
|
| 43 |
Valsartan and the renin-angiotensin-aldosterone system: blood pressure control and beyond
|
Dahlöf, Björn
|
|
2000
|
1 |
2 |
p. S14-S16
|
artikel
|
| 44 |
Will more complete inhibition of the RAAS with angiotensin receptor blockade improve survival following myocardial infarction?
|
Pfeffer, Marc A
|
|
2000
|
1 |
2 |
p. S41-S43
|
artikel
|
Tijdschrift beschrijving